BMJ Best Practice

参考文献

关键文献

Maguina C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am. 2000;14:1-22.

Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921-1933.

Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev Microbiol. 2004;58:365-390.

Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics. 2008;121:e1413-e1425.

Prutsky G, Domecq JP, Mori L, et al. Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis. 2013;17:e811-e819.

参考文章

1.  Jacomo V, Kelly PJ, Raoult D. Natural history of Bartonella infections (an exception to Koch's postulate). Clin Diagn Lab Immunol. 2002;9:8-18.

2.  Chomel BB, Boulouis HJ, Maruyama S, et al. Bartonella spp. in pets and effect on human health. Emerg Infect Dis. 2006;12:389-394.

3.  Okaro U, Addisu A, Casanas B, et al. Bartonella species, an emerging cause of blood-culture-negative endocarditis. Clin Microbiol Rev. 2017;30:709-746.

4.  Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev. 1997;10:203-219.

5.  Maguina C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am. 2000;14:1-22.

6.  Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14:177-207.

7.  Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol. 1993;31:872-881.

8.  Roux V, Eykyn SJ, Wyllie S, et al. Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human. J Clin Microbiol. 2000;38:1698-1700.

9.  Avidor B, Graidy M, Efrat G, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol. 2004;42:3462-3468.

10.  Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921-1933.

11.  Angelakis E, Lepidi H, Canel A, et al. Human case of Bartonella alsatica lymphadenitis. Emerg Infect Dis. 2008;14:1951-1953.

12.  Breitschwerdt EB, Maggi RG, Lantos PM, et al. Bartonella vinsonii subsp. berkhoffii and Bartonella henselae bacteremia in a father and daughter with neurological disease. Parasit Vectors. 2010;3:29.

13.  Bai Y, Kosoy MY, Diaz MH, et al. Bartonella vinsonii subsp. arupensis in humans, Thailand. Emerg Infect Dis. 2012;18:989-991.

14.  Jacobs RF, Schutze GE. Bartonella henselae as a cause of prolonged fever and fever of unknown origin in children. Clin Infect Dis. 1998;26:80-84.

15.  Jackson LA, Perkins BA, Wenger JD. Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health. 1993;83:1707-1711.

16.  Matteelli AF, Castelli A, Spinetti F, et al. Short report: verruga peruana in an Italian traveler from Peru. Am J Trop Med Hyg. 1994;50:143-144.

17.  Melter O, Arvand M, Votýpka J, et al. Bartonella quintana transmission from mite to family with high socioeconomic status. Emerg Infect Dis. 2012;18:163-165.

18.  Magnolato A, Pederiva F, Spagnut G, et al. Three cases of Bartonella quintana infection in children. Pediatr Infect Dis J. 2015;34:540-542.

19.  Relman DA. Has trench fever returned? N Engl J Med. 1995;332:463-464.

20.  Zangwill KM, Hamilton DH, Perkins BA, et al. Cat scratch disease in Connecticut - epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med. 1993;329:8-13.

21.  Telford SR 3rd, Wormser GP. Bartonella spp. transmission by ticks not established. Emerg Infect Dis. 2010;16(3):379-84.

22.  Byam W, Carroll JH, Churchill JH, et al. Trench fever: a louse-borne disease. London, UK: Oxford University Press; 1919.

23.  Brouqui P, Lascola B, Roux V, et al. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med. 1999;340:184-189.

24.  Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev Microbiol. 2004;58:365-390.

25.  Mandle T, Einsele H, Schaller M, et al. Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B henselae. Blood. 2005;106:1215-1222.

26.  Birtles RJ. Bartonellae as elegant hemotropic parasites. Ann N Y Acad Sci. 2005;1063:270-279.

27.  Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics. 2008;121:e1413-e1425.

28.  Jackson LA, Spach DH, Kippen DA, et al. Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis, 1996;173:1023-1026.

29.  Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med. 1996;125;646-652.

30.  Centers for Disease Control and Prevention. Bartonella infection (cat scratch disease, trench fever, and Carrión’s disease): prevention. December 2015. http://www.cdc.gov (last accessed 29 May 2017).

31.  Cheung VW, Moxham JP. Cat scratch disease presenting as acute mastoiditis. Laryngoscope. 2010;120 Suppl 4:S222.

32.  Fournier PE, Mainardi JL, Raoult D. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol. 2002;9:795-801.

33.  Margileth AM. Recent advances in diagnosis and treatment of cat scratch disease. Curr Infect Dis Rep. 2000;2:141-146.

34.  Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis. 2006;12:217-223.

35.  Maguina C, Guerra H, Ventosilla P. Bartonellosis. Clin Dermatol. 2009;27:271-280.

36.  Slater LN, Welch DF. Bartonella, Including Cat-Scratch Disease. In: Mandell, Douglas and Bennett , Principles and Practice of Infectious Diseases, 7th edition. Editors: Mandell GR, Bennett JE, Dolin R. Elsevier, Amsterdam, 2011.

37.  Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol. 2015;53:824-829.

38.  Prutsky G, Domecq JP, Mori L, et al. Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis. 2013;17:e811-e819.

39.  Raoult D, Fournier PE, Vandenesch F, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med. 2003;163:226-230.

40.  Bass JW, Freitas BC, Freitas AD, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998;17:447-452.

41.  Laham FR, Kaplan SL. Hepatosplenic cat-scratch fever. Lancet Infect Dis. 2008;8:140.

42.  Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1993;17:612-624.

43.  Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009;58(RR-11):1-166.

44.  Guerra LG, Neira CJ, Boman D,et al. Rapid response of AIDS-related bacillary angiomatosis to azithromycin. Clin Infect Dis. 1993;17:264-266.

45.  Bryant K, Marshall GS. Hepatosplenic cat scratch disease treated with corticosteroids. Arch Dis Child. 2003;88:345-346.

46.  Maguina C, Garcia PJ, Gotuzzo E, et al. Bartonellosis (Carrion's disease) in the modern era. Clin Infect Dis. 2001;33:772-779.

47.  Angelakis E, Biswas S, Taylor C, et al. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA. J Antimicrob Chemother. 2008;61:1252-1255.

48.  Reed JB, Scales DK, Wong MT, et al. Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology. 1998;105:459-466.

49.  Huarcaya E, Maguina C, Torres R, et al. Bartonelosis (Carrion's Disease) in the pediatric population of Peru: an overview and update. Braz J Infect Dis. 2004;8:331-339.

50.  Biswas S, Raoult D, Rolain JM. Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J Antimicrob Chemother. 2007;59:1065-1070.

51.  Maman E, Bickels J, Ephros M, et al. Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis. 2007;45:1535-1540.

使用此内容应接受我们的免责声明